- Insomnia news are updated once a hour
- We deliver news from more than 500 sources on insomnia
NewsAdvertisers: |
Valeant Pharma Says VISER1 Study Did Not Meet Non-Inferiority ......ba href=/insomnia/a/b, depression and myalgia. Copyright(c) 2006 RealTimeTraders.com, Inc. All Rights Reserved Return More BREAKING NEWS PREMIER SPONSORED LINKS Advertise Here VIX Options - A Revolutionary Product for Trading Volatility Try Forex Trading – No Commissions, Ever! $7 Trades at Scottrade, Ranked “Highest in Investor Satisfaction” Commodity info at Lind-Waldock Free Investors Secrets Book FREE Daily Futures Trading Ideas from the Pros. Sign Up Now! About TradingMarkets What Customers Are Saying All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy. © 2006 The Connors Group, Inc. ... Valeant Pharmaceuticals Reports VISER1 Results for Viramidine(R) ......ba href=/insomnia/a/b, depression and myalgia. VISER1 Trial Design The VISER1 trial (VISER stands for VIramidine's Safety and Efficacy vs. Ribavirin) evaluated a fixed 600 mg BID dose of Viramidine to a weight-based 1,000/1,200 mg daily dose of ribavirin, both in combination with peginterferon alfa 2b. The study, conducted in the United States, Canada, Europe, Israel, New Zealand and Australia, enrolled 970 treatment-naive subjects with chronic HCV. Treatment duration was based on genotype, with genotypes 2 and 3 receiving 24 weeks of treatment and genotype non 2, 3 receiving 48 weeks of treatment, each with a post-treatment follow-up period of 24 weeks. The study was stratified for genotype, weight and viral load. Additional information regarding the Phase 3 trial was furnished by the company today with the Securities and Exchange Commission on Form 8-K and is also available on the company's Web site at www.valeant.com. Conference Call and Webcast Information: Valeant will host a conference call today at 8:30 a.m. EST (5:30 a.m. PST) to discuss the VISER1 data results. The dial-in number to participate on this call is (877) 295-5743, confirmation code 6907744. International callers should dial (706) 679-0845, confirmation code 6907744. The company will also webcast the conference call live over the Internet. The webcast may be accessed through the investor relations section of Valeant's corporate Web site at www.valeant.com. Viramidine is an investigational compound that has not be... Insomnia disorders haunt 400 million Chinese...ba href=/insomnia/a/b, abruptly waking up, night sweats, rapid heartbeats during sleep and snoring.Many of them complain that their sleeping sessions are too short and that they often have trouble getting back to sleep, the report said.According to a separate survey among doctors in Beijing, Shanghai and Guangzhou, ba href=/insomnia/a/b is found in 75 per cent of depression patients.For Chinese children and students, the heavy burden of examinations for higher schools are also important causes of the problem, experts said.The majority of people with problems were found working in professions that require intense brainwork, including media workers and business leaders. Top Stories of the day: Indian share market breaches 11,000 mark on fund inflows Nawaz met Osama thrice, received funds to topple Benazir: ex-ISI officer Harpreet qualifies for boxing semis Left concerned over depleting staff strength in RBI High Court questions CBI clean chit to housing societies SBI employees strike from Apr 3 over pension revision India plans safety measures for NRIs in Gulf CWG: Aparna, Saina, Sridhar register easy wins in 1st round Brit women out drinking men! Government did not pay extra amount in Scorpene deal: Pranab Mukherjee Pak party accuses Afghanistan of interference in Waziristan Mines defused on Afghan's New Year Day Granholm to sign anti-abortion bill Biswas still on ventilatory support Vatican conference defends Crusades Akalis pledge legal aid to blast suspects before DSGMC polls COL BKB: Michigan 87, ... 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70 | 71 | 72 | 73 | 74 | 75 | 76 | 77 | 78 | 79 | 80 | 81 | 82 | 83 | 84 | 85 | 86 | 87 | 88 | 89 | 90 | 91 | 92 | 93 | 94 | 95 | 96 | 97 | 98 | 99 | All news |